Astrocytoma, Grade II Terminated Phase 2 Trials for Grn163l (DB05036)

IndicationStatusPhase
DBCOND0063156 (Astrocytoma, Grade II)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01836549Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsTreatment